Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

121. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2011 Authors' objectives Full (...) -field digital mammography (FFDM) is an alternative to conventional screen-film mammography (SFM), the standard of care for detecting breast cancer. With digital mammography, images of the breast are acquired, displayed, transferred, and stored as digital data for viewing on a computer monitor (soft-copy reading) or for printing and viewing with a light box (hard-copy reading). In contrast to SFM, FFDM simplifies image interpretation because image acquisition, image processing, image review, and data

2011 Health Technology Assessment (HTA) Database.

122. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. Full Text available with Trip Pro

Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. Women with a personal history of breast cancer (PHBC) are at risk of developing another breast cancer and are recommended for screening mammography. Few high-quality data exist on screening performance in PHBC women.To examine the accuracy and outcomes of mammography screening in PHBC women relative to screening of similar women without PHBC.Cohort of PHBC women, mammogram matched (...) to non-PHBC women, screened through facilities (1996-2007) affiliated with the Breast Cancer Surveillance Consortium.There were 58,870 screening mammograms in 19,078 women with a history of early-stage (in situ or stage I-II invasive) breast cancer and 58,870 matched (breast density, age group, mammography year, and registry) screening mammograms in 55,315 non-PHBC women.Mammography accuracy based on final assessment, cancer detection rate, interval cancer rate, and stage at diagnosis.Within 1 year

2011 JAMA

123. Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer

Background Breast cancer is a disease of aging with a four-fold higher incidence in women 50 to 69 years of age (500 per 100,000 women) compared to women 40 to 49 years of age (140 per 100,000 women). The estimated number of new breast cancer diagnoses in Ontario women 40 to 49 year of age is approximately 1,400 per year. There are approximately 1.02 million women in this age group in Ontario at present. The MAS review assessed the effectiveness of screening (film) mammography in women 40 to 49 years (...) Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer 1 OHTAC Recommendation Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer Updated January 2011 This recommendation summary has been prepared by the Medical Advisory Secretariat of the Ministry of Health and Long Term Care on behalf of the Ontario Health Technology Advisory Committee. Presented to the Ontario Health Technology Advisory Committee in November, 2010 Issue

2011 Health Quality Ontario

124. Organizational change: a way to increase colon, breast and cervical cancer screening in primary care practices

Organizational change: a way to increase colon, breast and cervical cancer screening in primary care practices Organizational change: a way to increase colon, breast and cervical cancer screening in primary care practices Organizational change: a way to increase colon, breast and cervical cancer screening in primary care practices Arroyave AM, Penaranda EK, Lewis CL CRD summary Organisational change interventions that circumvented the physician were most effective in increasing cancer screening (...) published in English between January 1990 and July 2010. Search terms were reported. References of relevant studies were handsearched for further studies. Study selection Eligible randomised controlled trials (RCTs) that reported the impact of organisational change interventions implemented by practice staff on colorectal, breast or cervical cancer screening rates. Eligible outcomes were test completion of flexible sigmoidoscopy, colonoscopy, faecal occult blood test, mammography, clinical breast

2011 DARE.

125. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis

Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

126. Effect of screening mammography on breast-cancer mortality in Norway. Full Text available with Trip Pro

Effect of screening mammography on breast-cancer mortality in Norway. A challenge in quantifying the effect of screening mammography on breast-cancer mortality is to provide valid comparison groups. The use of historical control subjects does not take into account chronologic trends associated with advances in breast-cancer awareness and treatment.The Norwegian breast-cancer screening program was started in 1996 and expanded geographically during the subsequent 9 years. Women between the ages (...) of 50 and 69 years were offered screening mammography every 2 years. We compared the incidence-based rates of death from breast cancer in four groups: two groups of women who from 1996 through 2005 were living in counties with screening (screening group) or without screening (nonscreening group); and two historical-comparison groups that from 1986 through 1995 mirrored the current groups.We analyzed data from 40,075 women with breast cancer. The rate of death was reduced by 7.2 deaths per 100,000

2010 NEJM

127. Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities

Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities – Clinical Correlations Search Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities May 6, 2010 5 min read | | 4 comments on “ Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities ” Comments are closed. Sites We Follow

2010 Clinical Correlations

128. Breast cancer mortality in organised mammography screening in Denmark: comparative study. Full Text available with Trip Pro

Breast cancer mortality in organised mammography screening in Denmark: comparative study. To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up.We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas (...) Denmark for 1971-2006.Annual percentage change in breast cancer mortality in regions offering mammography screening and those not offering screening.In women who could benefit from screening (ages 55-74 years), we found a mortality decline of 1% per year in the screening areas (relative risk (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.01) during the 10 year period when screening could have had an effect (1997-2006). In women of the same age in the non-screening areas, there was a decline of 2

2010 BMJ

129. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis

Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

130. A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach

A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 NHS Economic Evaluation Database.

131. Breast tomosynthesis: a breast cancer screening tool

Breast tomosynthesis: a breast cancer screening tool Horizon Scanning Technology Prioritising Summary Breast tomosynthesis: a breast cancer screening tool Update: November 2009 © Commonwealth of Australia 2009 ISBN Publications Approval Number: This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from any use as permitted under the Copyright (...) of Population Health and Clinical Practice, Mail Drop DX 650 545, University of Adelaide, Adelaide, SA, 5005. Breast tomosynthesis: November 2009 Update 1 PRIORITISING SUMMARY (UPDATE 2009) REGISTER ID: 000373 NAME OF TECHNOLOGY: BREAST TOMOSYNTHESIS PURPOSE AND TARGET GROUP: BREAST CANCER SCREENING TOOL 2009 COMPARATORS No new comparators were identified during the preparation of this update. 2009 SAFETY AND EFFECTIVENESS ISSUES A study by (Teertstra et al 2009) investigated digital mammography

2009 Australia and New Zealand Horizon Scanning Network

132. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. (Abstract)

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population.The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update (...) and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

2009 Annals of Internal Medicine

133. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. Full Text available with Trip Pro

Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. This systematic review is an update of evidence since the 2002 U.S. Preventive Services Task Force recommendation on breast cancer screening.To determine the effectiveness of mammography screening in decreasing breast cancer mortality among average-risk women aged 40 to 49 years and 70 years or older, the effectiveness of clinical breast examination and breast self-examination, and the harms (...) of screening.Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2008), MEDLINE (January 2001 to December 2008), reference lists, and Web of Science searches for published studies and Breast Cancer Surveillance Consortium for screening mammography data.Randomized, controlled trials with breast cancer mortality outcomes for screening effectiveness, and studies of various designs and multiple data sources for harms.Relevant data were abstracted

2009 Annals of Internal Medicine

134. Rethinking screening for breast cancer and prostate cancer. Full Text available with Trip Pro

be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. (...) Rethinking screening for breast cancer and prostate cancer. After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may

2009 JAMA

135. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management

Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

136. Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Full Text available with Trip Pro

been shown for CBE or BSE. Project page URL Final publication URL Indexing Status Subject indexing assigned by NLM MeSH Adult; Age Factors; Aged; Anxiety /etiology; Breast Neoplasms /diagnosis /mortality; Breast Self-Examination; Early Detection of Cancer; Female Costss; Magnetic Resonance Imaging /economics; Mammography /adverse effects /economics /methods; Mass Screening /economics /methods; Middle Aged; Palpation /economics; Risk Factors Language Published English Country of organisation United (...) Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L Record Status This is a bibliographic record of a published health technology assessment from a member

2009 Health Technology Assessment (HTA) Database.

137. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

138. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

2009 Health Technology Assessment (HTA) Database.

139. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Article Text Treatment Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright

2008 Evidence-Based Nursing

140. Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women

Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after

2008 Evidence-Based Medicine